2018
DOI: 10.1097/igc.0000000000001328
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience

Abstract: Recent research has shown that the most profound impact on survivorship occurs when women get proper care from surgeons trained in the latest techniques for treating ovarian cancer. Completion surgery maintained that even after initial incomplete cytoreduction outside of the high specialized units, after applying appropriate surgery techniques macroscopically, disease-free situation is achievable and outcomes are comparable with the results of primary debulking surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 30 publications
(22 reference statements)
1
6
0
Order By: Relevance
“…If preoperative CT-PCI could mimic the operative S-PCI, it would be an excellent tool for assessing the resectability of a tumor, since S-PCI is a good indicator of OS, [4,19]. In the present study, CCS resulted in a signi cantly longer OS compared with patients with residual disease < 10 mm and those with suboptimal debulking (residual disease ≥ 10 mm), in line with previous studies [5,11]. This study intended to elucidate whether patients with residual disease over 10 mm could be identi ed preoperatively, since CT-PCI correlated with intraoperative PCI (S-PCI).…”
Section: Discussionsupporting
confidence: 88%
“…If preoperative CT-PCI could mimic the operative S-PCI, it would be an excellent tool for assessing the resectability of a tumor, since S-PCI is a good indicator of OS, [4,19]. In the present study, CCS resulted in a signi cantly longer OS compared with patients with residual disease < 10 mm and those with suboptimal debulking (residual disease ≥ 10 mm), in line with previous studies [5,11]. This study intended to elucidate whether patients with residual disease over 10 mm could be identi ed preoperatively, since CT-PCI correlated with intraoperative PCI (S-PCI).…”
Section: Discussionsupporting
confidence: 88%
“…In patients undergoing USO or BSO, comprehensive surgical staging should still be performed in most patients to rule out occult higher-stage disease, because data show that approximately 30% of patients (with presumed early-stage disease) are upstaged after undergoing complete staging surgery. 23,27,28,[112][113][114][115][116] Comprehensive surgical staging may be omitted in pediatric/ adolescent patients with clinically apparent early-stage malignant germ cell tumors based on the pediatric surgical literature suggesting that incomplete staging does not result in poorer outcomes (OS). 117 For adults with apparent stage I malignant ovarian germ cell tumors, comprehensive staging is recommended based on results from retrospective studies suggesting that incomplete surgical staging may be associated with increased risk of recurrence 118,119 ; although others found no relationship between incomplete staging and DFS.…”
Section: Fertility Sparing Options For Stage I Diseasementioning
confidence: 99%
“…The standard therapy for ovarian cancer is the combination of maximal surgical effort and platinum-based chemotherapy [8,9]. Surgical outcome [10] has been proven to be a main predictive factor for the patients' outcome, with the highest benefit obtained at total macroscopic tumor clearance [11].…”
Section: Introductionmentioning
confidence: 99%